panaceachronicles

Pure, Natural Coca Leaf – A Healing Gift Of The Divine Plant

Tag Archives: anti-smoking


by Leave a comment

Your Money And Your Life

The bigger they are …

Highwaymen in the Middle Ages gave travelers a choice – they could hand over their cash and all their possessions, or they could hand over their life. At least those criminals gave their victims a choice.

Big tobacco wants both. “They just keep lining up for a smoke, so we grab ’em, drain ’em, and toss ’em aside – there’s plenty more coming down the highway. “

This post offers you an inside look at how Big Tobacco spreads its money around to buy scientists and regulators in order to create meaningless tobacco regulations based on purposely faked science so they can say “See, we’re playing by the rules, so you can’t touch us.” 

Well, I do believe that Big Tobacco has outsmarted itself with its attempt to move smokers away from smoking and into vaporizing. That’s because in order to accomplish this massive feat of social engineering Big Tobacco has inadvertently revealed some things about their industrial practices that will, when clearly understood, point directly to their massive corporate crimes.

This post is an excerpt from a World Health Organization internal document titled: “Tobacco Company Strategies to Undermine Tobacco Control Activities at the World Health Organization”. This 250 page report reveals the extent of Big Tobacco’s subversion, corruption, intimidation and seduction of scientists, regulators, institutions, and anti-tobacco efforts worldwide. WHO estimates that by 2050 Big Tobacco will have killed 1 Billion people in its rampage, and this is a detailed look at how it has managed to accomplish the miracle of killing millions of people for profit and never being held criminally accountable.

This courageous and powerful report reveals in great detail the remarkable efforts Big Tobacco makes to cover its tracks, and it seems pretty clear that the only reason it would go to that enormous trouble and expense would be if they knew that if the truth about what they are really up to were to get out there, and if the truth could break through all that very expensive social engineering they’ve been doing for decades, they would all be doing the CNN perpwalk.

The reason this is relevant to a blog on Coca and Cannabis is that if you look closely at the methods Big Tobacco has used to systematically subvert scientists and government agencies worldwide to protect itself and pursue its goals, you can explain a lot of otherwise puzzling and inconsistent things about the American “War on Drugs”. After you read the following excerpt, and maybe the whole WHO report, see if you don’t agree with me that the “War on Drugs” has had the smell of Big Tobacco all over it since the 1970’s.

THE REPORT, Section Seven: “Subverting Science And Health”

Distorting WHO Research

Tobacco companies have a long history of distorting science to oppose restrictions on tobacco. Some of the tactics the tobacco companies have used for decades to manipulate the scientific and public debate include:

1.     Secretly Funding Speakers at WHO Conferences

Tobacco companies have attempted to influence the tone and content of WHO- sponsored scientific conferences by paying “independent” scientists to attend and present papers. For example, Japan Tobacco Inc. (JTI) planned to pay 40 scientists to “present ‘neutral’ papers” at the 6th World Health Conference on Smoking or Health held in Japan in 1987.117 JTI calculated that the 40 scientists they would plant at the conference would exert significant influence:

“J.T.I. is trying to change the very nature and tone of the conference through these efforts.”118

INFOTAB, too, planned to encourage the submission of papers favorable to tobacco companies to the 6th WCToH.119

JTI also planned to get a scientific foundation controlled by tobacco companies (SRFS) involved as a member of the Academic Committee for the conference, to permit JTI to participate in the screening of papers for the conference:

“If the SRFS can send members to this committee, ‘neutral’ papers could be submitted to the conference.”120

2.     Holding Scientific Symposia to Promote Pro-Industry Positions, with Tobacco Companies’ Role Concealed

As part of its campaign to undermine the IARC ETS study, tobacco companies arranged for several symposia on ETS at which speakers chosen for views consistent with the tobacco companies’ position would present papers. Tobacco company sponsorship of some of these symposia was concealed or minimized. Some of these conferences were primarily sponsored by tobacco company front organizations, such as Healthy Buildings International and CIAR.121 The views expressed at the symposia were disseminated by tobacco companies as “independent” scientific viewpoints.122

3.     Misrepresenting Tobacco Company Work as WHO- Supported

In an apparent attempt to enhance the credibility of a tobacco company-sponsored ETS conference, industry officials widely misrepresented the conference as WHO- sponsored, based on the attendance at the conference of a single WHO official.123

4.     Using “Independent” Consultants with Concealed Tobacco Company Ties to Lobby WHO Scientists

Echoing its use of front organizations as surrogates, tobacco companies have used outside scientists with concealed tobacco company ties to approach and lobby WHO on scientific questions related to tobacco.

5.     Contacting WHO Study Scientists to Influence Study Results

As part of their plan to undermine the IARC ETS study, tobacco companies set out to establish contacts with the study investigators and collaborators.124  With some exceptions,125 the tobacco companies arranged to have contacts made through outside scientists acting as tobacco company consultants.126 The tobacco company affiliation of the consultants who contacted the IARC investigators was frequently concealed.127 These contacts with IARC scientists were to be used to gather “the best information about the status and likely findings of the study,”128 convince study investigators of the weaknesses of the IARC study,129 and, ultimately, achieve “the objective of no report or a report which draws mild conclusions from its data.”130

Through their contacts with IARC investigators and collaborators the tobacco companies were successful in gaining a large amount of information about the design and conduct of the study. More importantly, they were able to gain confidential information about preliminary study results and about how the study was likely to be interpreted. The tobacco companies were not able to influence the outcome of the study, however.

6.     Presenting Tobacco Company Arguments Through “Independent” Scientists with Concealed Tobacco Company Ties

Tobacco companies’ scientific consultants have also lobbied WHO on scientific issues without revealing their tobacco company ties. For example, Peter Lee, a tobacco company consultant, wrote to the Director-General of WHO,131 apparently at BAT’s request, providing a lengthy criticism of a WHO study of mortality from tobacco use. In his letter, Lee described himself as “an independent statistician/epidemiologist who has followed the literature on smoking and health very closely for over 20 years.” He did not disclose any tobacco industry affiliations.132

7.     Compromising Independence and Credibility of WHO Studies by Involving Investigators in Tobacco Company Research or Activities

Tobacco companies, through their front organization CIAR, attempted to involve IARC and its investigators in collaborative ventures. These ventures included (1) using IARC investigators to conduct studies on ETS confounders that could be used by tobacco companies to challenge the IARC study, (2) offering research grants to IARC investigators, and (3) offering to put an IARC investigator on CIAR’s advisory board.133

According to the study coordinator, IARC itself did not pursue any proposed collaboration once IARC became aware of CIAR’s tobacco company connections.134 One IARC collaborator did, however, conduct a study for CIAR on confounders. The tobacco companies’ purpose in using an IARC collaborator was almost certainly to undermine the IARC study results by attempting to produce evidence, under the name of one of IARC’s own investigators, that would undercut the study.

Tobacco companies conducted and publicly promoted a large number of studies, conferences, and literature reviews on ETS that were designed to challenge the validity of the IARC ETS study. These activities were generally carried out through third parties to create the appearance that the data and opinions were independent of tobacco industry influence.

The data from these studies were used successfully by industry officials when the IARC study results were released to cast doubt on the study. For example, the Sunday Telegraph cited the tobacco company-financed studies as evidence that:

“Passive smokers inhale the equivalent of just six cigarettes a year from other people’s smoke, according to the largest ever study of actual exposure levels of non-smokers. The figure, which undermines previous warnings about the dangers of passive smoking, is a thousand times lower than that faced by direct smokers, and so tiny that it could not be measured statistically.”135

8.     Creating an Ostensibly Independent Coalition of Scientists

Tobacco companies sought to create an ostensibly independent coalition of scientists in Europe to help criticize the IARC study and other scientific studies used to support tobacco control policies.136 Like The Advancement of Sound Science Coalition (TASSC) created by Philip Morris and a public relations firm in the US, the European group would appear to be independent but would be initiated and funded by tobacco companies and by other industries.137

The committee of experts was unable to determine the success of this plan. Ong and Glantz have reported, however, that the likely outcome of this initiative was the European Science and Environment Forum (ESEF),138 although ESEF claims to receive little or no tobacco industry funding.139 ESEF has listed on its website at least two working papers criticizing the IARC ETS study, and the methods used in ETS epidemiological studies.140  Lorraine Moody, ESEF’s “key contact,”141 wrote an opinion piece in the Wall Street Journal claiming that the IARC study showed a possibly “trivial or nonexistent” risk of lung cancer from ETS, demonstrating that the health risks of ETS are overstated.142

9.     Misrepresenting Scientific Studies to the Media and Regulators

The results of the IARC ETS study, released in 1998, showed that non-smoking spouses of smokers have an estimated 16% increased risk of developing lung cancer and that non-smokers exposed to ETS in the workplace have an estimated 17% increased risk of developing lung cancer.143 IARC’s reported results were consistent with the results of other ETS studies, showing an increased risk of lung cancer for nonsmokers exposed to ETS by a spouse or in the workplace.144 However, there were not enough subjects in the study for the increased risk to reach “statistical significance,” using common statistical methods (i.e., at the 95% confidence level).145

Shortly after the results of the IARC ETS study were released, BAT issued a press release stating: “New scientific research from the World Health Organization has shown the risk of lung cancer from environmental tobacco smoke to be either non-existent or too small to be measured at a meaningful level.”146 Thus, BAT claimed that the lack of statistical significance was equivalent to a finding that there was no relationship between ETS and lung cancer. These claims were picked up first by the Sunday Telegraph and then by other news outlets.

Despite subsequent clarifying statements from IARC and WHO about the study results, the misrepresentation of the study results in the BAT news release was repeated in media accounts around the world. Tobacco companies may also have distorted the IARC study results when addressing regulatory authorities.

10.  Staging Media Events or Other Diversions to Discredit or Distract Attention from WHO Tobacco Control Activities

Tobacco companies planned a series of distractions from the 8th World Conference on Tobacco OR Health.  These plans, at  least some of which were carried out, included a media campaign just before the 8th WCToH, emphasizing the need for childhood immunizations; a major soccer game to distract attention from Jimmy Carter’s arrival; training journalists to disrupt a press conference held by the conference organizers; and embarrassing US Senator Ted Kennedy by planting journalists to ask questions about drinking and sexual harassment allegations.

One unattributed BAT document with the handwritten title “Dietrich/WHO” on the title page also planned an event, called the “Global Children’s Health Conference,” to “distract the media from extensive coverage of the May 31, 1990 International Anti- Smoking Day and the 1990 theme of Smoking and Children.”147 According to the document, through the Institute  for IIHD, run by Paul Dietrich (see Chapter VI), BAT would hold a conference for business and government leaders and launch a longer- term strategy to increase private funding for children’s health issue. In describing the program strategy, the BAT document states:

“ The event will be staged to pre-empt monitored WHO meetings and conferences“,150 had confidential WHO contacts,151 and obtained confidential documents and information.152 Examples of clandestine surveillance activities are described in several of the case studies.

“The conference can facilitate the development of a long-term initiative to counteract the WHO’s anti- smoking campaign 

“At no time during the event will the issue of smoking be addressed…

“…Design the Conference to address primary health needs of children underscoring the ‘real crisis’. Develop an oblique critique of WHO’s anti- smoking campaign which identifies it as trivial when the global infants’ and children’s crisis is evaluated.

“Introduce alternative solutions which, in the long-term, could successfully undermine the WHO’s overall mandate.”148

It appears that BAT did not carry through with this conference.

11.  Conducting Systematic Surveillance of WHO Activities

Tobacco companies have carried out intensive monitoring of WHO and its Regional Offices to gather intelligence about its tobacco control programs.149

Some of the industry’s intelligence-gathering has been conducted openly, through attendance at open meetings and conferences and through open contacts with WHO and other UN officials.

There is also evidence, however, that tobacco companies have secretly monitored conferences,150 had confidential WHO contacts,151 and obtained confidential documents and information.152

Examples of clandestine surveillance activities are described in several of the case studies.

This ends the excerpt. You can read and download the full 250 page UN Report in PDF format here:

“Tobacco Company Strategies to Undermine Tobacco Control Activities at the World Health Organization” 

If you are inclined to look at references, here they are – just for this section. The entire report contains thousands of similarly damning references that put the moral degradation and greed of this industry on full display. And they really don’t care, because they have convinced themselves that they are untouchable. They would do well to remember – Al Capone was brought down by a simple little tax violation and not by any of his vast criminal conspiracies and crimes. 

I think that the industry’s attempt to engineer a shift from smoking to vaporizing is going to reveal the tobacco industry’s equivalent of a simple little tax evasion crime that will be enough, when all the evidence is brought to bear, for the initiation of a crimes against humanity trial in the World Court that will ultimately result in worldwide government and civil seizure of tobacco industry assets.

Notes & References

WHOIIOCUIUICC: Strategies and Tactics. January 31, 1989. Philip Morris Companies Inc. 2501045143–5147 at 5143. www.pmdocs.com. UQ 32846.

Appendix I, INFOTAB January 1989 Discussion Paper. January 30, 1989. Philip Morris Companies Inc. 2501045258–5268 at 5262. www.pmdocs.com. UQ 33561.

World Watch: Protecting our Global ‘Next Generation’-A Proposed Conference on Children’s Health Issues. October 1989. 300516227–6285 at 6235. Guildford Document Depository. UQ 33691.

WHOIIOCUIUICC: Strategies and Tactics. January 31, 1989. Philip Morris Companies Inc. 2501045143–5147 at 5143. www.pmdocs.com. UQ 32846.

Hartogh JM. To all members of the ICOSI task force 4th world conference on smoking and health. [Memo by E. Brueckner.] June 26, 1979. British American Tobacco Company. 100433043–3047 at 3046. Guildford Document Depository. UQ 33162.

WHOIIOCUIUICC: Strategies and Tactics. January 31, 1989. Philip Morris Companies Inc. 2501045143–5147 at 5146. www.pmdocs.com. UQ 32846.

Appendix I, INFOTAB January 1989 Discussion Paper. January 30, 1989. Philip Morris Companies Inc. 2501045258–5268. www.pmdocs.com. UQ 33561.

WHOIIOCUIUICC: Strategies and Tactics. January 31,  1989. Philip Morris Companies  Inc. .2501045143–5147  at  5146. www.pmdocs.com. UQ 32846.

PMI Corporate Affairs Action Plan 1990. November 2, 1989est. Philip Morris Companies Inc. 2500019979–9999 at 9980–9982. www.pmdocs.com. UQ 33558.

Sullivan J. IARC Study. September 2, 1993. Philip Morris Companies Inc. 2501117793– 7797 at 7795. www.pmdocs.com. UQ 33603

Egawa E. April 25, 1986. Philip Morris Companies Inc. 2021654119–4123. www.pmdocs.com. UQ 66.

Bloxidge JA. International Tobacco Growers’ Association (ITGA). October 11, 1988. British American Tobacco Company. 502555415–5417 at 5417. Guildford Document Depository. UQ 33284.

Boyse S. 8th World Conference on Tobacco and Health. August 28, 1991. British American Tobacco Company. 202019292–9293 at 9292. Guildford Document Depository. UQ 33262.

Bible G. Corporate Affairs Conference I Action Plan. December 13, 1986. Philip Morris Companies Inc. 2021596422–6432 at 6429. www.pmdocs.com. UQ 32834.

Appendix I, INFOTAB January 1989 Discussion Paper. January 30, 1989. Philip Morris Companies Inc. 2501045258–5268. www.pmdocs.com. UQ 33561.

Interview with Alan Lopez, Coordinator, Epidemiology and Burden of Disease, World Health Organization, May 4, 2000.

Oldman M. [Letter to G Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5363. Guildford Document Depository. UQ 33278.

Agro-Tobacco Services-Programme Review No1. 1992. British American Tobacco Company. 502552606–2611 at 2609. Guildford Document Depository. UQ 33290.

Interview with Alan Lopez, May 4, 2000.

Lee PN. Dr. Helmut Schievelbein. August 9, 1979. Philip Morris Companies Inc. 2501159889–9891 at 9889. www.pmdocs.com. UQ 33717.

Minutes of the Meeting of the Working Group of the E.E.C. Tobacco  Manufacturers’ Associations, Held in Luxemburg on 4th and 5th October 1979. November 11, 1979. Philip

Morris Companies Inc. 2501015083–5096 at 5088. www.pmdocs.com. UQ 33716.

Belcher P. Scientific Committee on Tobacco and Health (SCTH). February 9, 1994. Rothmans International. Philip Morris Companies Inc. 2024188905–8907 at 8905. www.pmdocs.com. UQ 33715.

Independent Scientific Review of the Toxic Substances Board Report, May 1989, Summary, Commissioned by the Tobacco Institute of New Zealand. 1989est. Philip Morris Companies Inc. 2504203558–3559. www.pmdocs.com. UQ 33535.

Collett C. Memo to Ted Sterling re: International Symposium on Environmental Tobacco Smoke, November 3-4, 1989.

November 1989est. Philip Morris Companies Inc. 2062856942. www.pmdocs.com. UQ 33536.

Rothman’s International Tobacco ETS Workshop. May 1992est. Philip Morris Companies Inc. 2501237099. www.pmdocs.com. UQ 33532.

25 . Pen Pictures of Guest Speakers. May 1992est. Philip Morris Companies Inc. 2501237101– 7103 at 7101. www.pmdocs.com. UQ 33531.

S&H. Re: Dr. Furst-Review of Non-Smoker Problem CTR Special Pro}ect. 1976est. Lorillard Tobacco Company. 03747419. TDO Supersite at www.tobaccodocuments.org. UQ 33714.

From the record before Congress, the Case for Defeat of S. 772. 1983est. Tobacco Institute. TIMN 0353310–3320 at 3312. TDO Supersite at www.tobaccodocuments.org/. UQ 33729.

Purvis A, Johnson J. Privileged and confidential attorneyIclient connumications. Trial Report, SummaryITestimonyIPro}ection. April 21, 1988. Philip Morris Companies Inc. 2025880540– 0543. Bliley Documents at www.tobaccodocuments.org. UQ 33730.

Tobacco Institute Newsletter. March 12, 1982. Philip Morris Companies Inc. 515841024. Bliley Documents at www.tobaccodocuments.org. UQ 98.

Hoel D. Confidential-For counsel only. July 10, 1979. Philip Morris Companies Inc.

  1. Bliley Documents at www.tobaccodocuments.org. UQ 99.

Tobacco Institute Newsletter. March 12, 1982. Philip Morris Companies Inc. 515841024. Bliley Documents at www.tobaccodocuments.org. UQ 98.

Lyberopoulos H. ARISE 1994-95 Activities and Funding. Philip Morris Companies Inc. 2024208096–8099. www.pmdocs.com. UQ 33779.

Information on Associates for Research in Substance En}oyment Meeting in Venice. 1991est. R.J. Reynolds Tobacco Company. 508300651–0667 at 0652. http://www.rjrtdocs UQ 33749.

Wilhelmus J. WHO. April 18, 1995. Philip Morris Companies Inc. 2063625254. www.pmdocs.com. UQ 33541.

Luik J, Snel J, Warburton D. ARISE (Associates for Research into the Science of En}oyment): A Summary of the Workshop Held in April 1995. April 1995est. R.J. Reynolds  Tobacco Company.  511818234–8241. www.rjrtdocs.com. UQ 33731.

The World Health Organization. December 1985est. Philip Morris Companies Inc. 2023267436. www.pmdocs.com. UQ 46.

36 . Reif H. Continuation of the Vettorazzi Pro}ect. March 25, 1992. Philip Morris Companies Inc. PM 2025594741–4743 at 4742. http://www.pmdocs.com. UQ 33466.

Consultant to ICOSI on International Organisations. August 1980est. Philip Morris Companies Inc. 2025049734. www.pmdocs.com. UQ 37.

Developing Countries Group (DCG). Progress report covering events since the ICOSI board of directors meeting October  5I8th,  1980. February 1981est. Philip Morris Companies Inc. 2025049364–9374 at 9365. www.pmdocs.com. UQ 40.

Hauser. [Letter to AG Leeks]. April 20, 1983. Philip Morris Companies Inc. 2023273908– 3909. www.pmdocs.com. UQ 42.

Secretariat Interim Report. December 28,1984. Philip Morris Companies Inc. 2023272512– 2617 at 2514. www.pmdocs.com. UQ 43.

CASIN. January 11, 1991. British American Tobacco Company. 300557237–7259 at 7241. Guildford Document Depository. UQ 33350.

CASIN. January 11, 1991. British American Tobacco Company. 300557237–7259 at 7240. Guildford Document Depository. UQ 33350.

CASIN. January 11, 1991. British American Tobacco Company. 300557237–7259 at 7256. Guildford Document Depository. UQ 33350.

Interviews with Neil Collishaw, Leanne Riley, and Barbara Zolty, all former employees of the WHO’s Tobacco or Health Program, Feb. 4, 2000.

Boca Raton Action Plan: WHOIIOCUIUICC: Strategies and Tactics. Philip Morris Companies Inc. 2501045143–5147 at 5146. www.pmdocs.com. UQ 32846.

E–mail communication from Neil Collishaw. March 29, 2000.

Interviews with Neil Collishaw, Barbara Zolty, and Leanne Riley, February 4, 2000.

E–mail communication from Barbara Zolty, March 2, 2000.

Sullivan J. IARC Study. September 2, 1993. Philip Morris Companies Inc. 2501117793– 7797 at 7795. www.pmdocs.com. UQ 33603.

Von Maerestetten C. IARC. July 26, 1993. Philip Morris Companies Inc. 2025493295. www.pmdocs.com. UQ 33776.

IARC Study. Philip Morris Companies Inc. 2501347168–7173 at 7172. www.pmdocs.com. UQ 33595.

Pages R. Update 2: IARC study of ETS and lung cancer. August 2, 1993. Philip Morris Companies  Inc. 20232999819. http://www.pmdocs.com.  UQ 33733.

Memo on vaccines for world health organization. October 25, 1971. Philip Morris Companies Inc. 2012581044. www.pmdocs.com. UQ 4.

Boca Raton Action Plan: WHOIIOCUIUICC: Strategies and Tactics. Philip Morris Companies Inc. 2501045143–5147 at 5146. www.pmdocs.com. UQ 32846.

Flavor and Extract Manufacturers Association. Invoice. August 17, 1995. Philip Morris Companies Inc. 2050761274. http://www.pmdocs.com. UQ 33546.

Schrankel K. Final Report to Contributors of Anethole Research Fund. August 25, 1998. Philip Morris Companies Inc. 2063597040. www.pmdocs.com. UQ 33548.

Minutes of Anethole Task Force. May 2, 1996. Philip Morris Companies Inc. 2063616600. www.pmdocs.com. UQ 33547.

Minutes of Anethole Task Force. May 2, 1996. Philip Morris Companies Inc. 2063616600. www.pmdocs.com. UQ 33547.

Schrankel. Final Report to Contributors of Anethole Research Fund. August 25, 1998. Philip Morris Companies Inc. 2063597040. www.pmdocs.com. UQ 33548

TIMN270055–0059 at 0058. http://www.tobaccoinstitute.com. UQ 32904.

Hartogh JM. To all members of the ICOSI task force 4th world conference on smoking and health. [Memo by E. Brueckner.] June 26, 1979. British American Tobacco Company.

100433043–3047. Guildford Document Depository. UQ 33162.

Oldman M. [Letter to G Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5358. Guildford Document Depository. UQ 33278.

  1. Developing Countries Ad Hoc Group (DCG). Progress Report Covering Events Since the ICOSI Board of Directors Meeting on 19th February, 1980. August 1980est.

  2. Philip Morris1987. British American Tobacco Company. 301760973–0979 at 0979. Guildford Document

 Depository. UQ 33254

Appendix I, INFOTAB January 1989, Discussion Paper. January 30, 1989. Philip Morris Companies Inc. 2501045258–5268 at 5262. Minnesota Document Depository. UQ 33561.

Pro}ect Report Covering Pro}ects and Action Plans Since the Board of Directors Meeting on March 30, 1981. 1981est. Philip Morris Companies Inc. 2025048077–8088 at 8077. www.pmdocs.com. UQ 41.

                Pro}ect Report Covering Pro}ects and Action Plans Since the Board of Directors Meeting on March 30, 1981. 1981est. Philip Morris Companies Inc. 2025048077–8088 at 8082. www.pmdocs.com. UQ 41.

Verkerk H. Fifth World Conference on Smoking and Health-Winnepeg.  Philip  Morris Companies Inc. 2501021564–1586 at 1577. www.pmdocs.com. UQ 32888.

Secretariat Interim Report. December 28, 1984. Philip Morris Companies Inc. 2023272512– 2617 at 2594. www.pmdocs.com. UQ 43.

Marcotullio. INFOTAB Board of Director’s (BOD) Meeting-March 30, 1981. April 6, 1981. 502741855. Bliley Documents at www.tobaccodocuments.org. UQ 60.

Witt S. International Committee on Smoking Issues Lausanne-November 10-12, 1977.

November 18, 1977. 502330545. Bliley Documents at www.tobaccodocuments.org. UQ 61.

Schlosser A, Mine K (Chadbourne, Parke). Representative Compilation of Literature Describing the Benefits of Tobacco. April 29, 1986. Brown & Williamson Company. 681870460–0654 at 0602. Bliley Documents at

www.tobaccodocuments.org.  UQ 64.

INFOTAB. INFOTAB Workshop. Undated. Philip Morris Companies Inc. 2501021710– 1711. www.pmdocs.com. UQ 32891.

Hauser. April 20, 1983. Philip Morris Companies Inc. 2023273908. www.pmdocs.com. UQ 42.

Secretariat Interim Report. December 28, 1984. Philip Morris Companies Inc. 2023272512– 2617 at 2594. www.pmdocs.com. UQ 43.

Simpson B, Hauser N. Background Papers for the INFOTAB Advisory Group Meeting, December, 5-7, 1983. November 25, 1983.

Brown & Williamson Tobacco Company. 699101438–1473. www.bwdocs.aalatg.com. UQ 32853.

International Organizations Monitoring Service. Industry Sectors and International Organizations-Tobacco Update and Outlook on World Health Organization Activities Affecting MNCs. March 5, 1986.  Philip  Morris Companies Inc. 2024272808- 2814 at 2812. Bliley Documents at www.tobaccodocuments.org. UQ 33777.

Oldman M. [Letter to D. Bacon, enclosing “Agro-Tobacco Services (ATS), Proposal for a Consultancy Agreement”]. January 7, 1992. British American Tobacco Company. 502552644–2654 at 2650. Guildford Document Depository. UQ 33302.

Oldman M. [Letter to D. Bacon, enclosing “Agro-Tobacco Services (ATS), Proposal for a Consultancy Agreement”]. January 7, 1992. British American Tobacco Company. 502552644–2654 at 2647. Guildford Document Depository. UQ 33302.

Oldman M. [Letter to G. Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5361. Guildford Document Depository. UQ 33278.

Oldman M. [Letter to G. Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5358. Guildford Document Depository. UQ 33278.

Oldman M. [Letter to G. Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5361. Guildford Document Depository. UQ 33278.

Oldman M. [Letter to D Bacon enclosing Agro- tobacco Activity Report for January 1993]. February 10, 1993. British American Tobacco Company. 502552508–2513 at 2512–2513. Guildford Document Depository. UQ 33296.

Oldman M. Paper for ITGA General Meeting, 1994. 1994est. British American Tobacco

Document Depository. UQ 33256.

Bacon D. Development Aid, Progress. November 28, 1991. British American Tobacco Company. 202049931–9932 at 9931. Guildford Document Depository. UQ 33256.

Bacon D. Development Aid, Progress. November 28, 1991. British American Tobacco Company. 202049931–9932 at 9932. Guildford Document Depository. UQ 33256.

Bible G. Corporate Affairs Conference I Action Plan. December 13, 1988. Philip Morris Companies Inc. 2021596422–6432 at 6429. www.pmdocs.com. UQ 32834.

Boca Raton Action Plan: Status Report for the Period Ending January 31, 1989. January 31, 1989. Philip Morris Companies Inc. 2500103969–4056 at 3989. www.pmdocs.com. UQ 32863.

Boyse S. [Letter to Peter Hazel, David Bacon, and JJ Mostyn]. August 8, 1991. British American Tobacco Company. 304004032. Guildford Document Depository. UQ 33184

Dietrich P. WHO spends money on what? The Wall Street Journal, May 9, 1989. UQ 33662.

Oldman M. [Letter to D. Bacon enclosing Activity Report, September/October 1993]. November 1, 1993. British American Tobacco Company. 502555329–5331 at 5331. UQ 33276.

Boca Raton Action Plan: Status Report for the Period Ending May 31, 1989. May 31, 1989. Philip Morris Companies Inc. 2021592752– 2764 at 2752. www.pmdocs.com. UQ 32859.

Boca Raton Action Plan: Status Report Ending July 31, 1989. July 31, 1989. Philip Morris Companies Inc. 2023547120–7135 at 7121. www.pmdocs.com. UQ 32860.

Boca Raton Action Plan Summary Report December 3, 1988-October 30, 1989. October 30, 1989. Philip Morris Companies Inc. 2503005015–5050. www.pmdocs.com. UQ 32862.

Oldman M. [Letter to D. Bacon enclosing Activity Report, September/October 1993]. November 1, 1993. British American Tobacco Company. 502555329–5331 at 5331. UQ 33276

Ntaba H. Letter to the Editor, International Health and Development, Vol. 1, No. 2, Summer, p. 31. UQ 33689.

Boca Raton Action Plan: Status Report for the Period Ending September 30, 1989. September 30, 1989. Philip Morris Companies Inc. 2501204997–5021 at 4998. www.pmdocs.com. UQ 32861.

Boyse S. [Letter to Paul Dietrich]. August 7, 1991. British American Tobacco Company. 300516113. Guildford Document Depository. UQ 33571.

Rupp J. Statement, Philip Morris International (Latin America). November 30, 1992. Philip Morris Companies Inc. 2023591405. www.pmdocs.com. UQ 32903.

Bacon D. Who Benefits from WHO? November 24, 1993. British American Tobacco Company.

  1. UQ 33311.

Agenda: “Primer Encuentro de Periodistas Y la Industria Del Tabaco.” June 1991est. British American Tobacco Company.  300565679– 5681. Guildford Document Depository. UQ 33675.

BAT Smoking Issues Briefing, Taiwan. September 6–8, 1992. British American

Tobacco Company. 300565674–5675. Guildford Document Depository. UQ 33677.

Agenda, Meeting of Social Communicators and the Tobacco Industry. November 1992est.

British American Tobacco Company. 300565668–5671. Guildford Document Depository. UQ 33678.

Oldman M. [Letter to G. Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5359. Guildford Document Depository. UQ 33278.

Bloxidge JA. International Tobacco Growers’ Association (ITGA). October 11, 1988. British American Tobacco Company. 502555415– 5417. Guildford Document Depository. UQ 33284.

Oldman M. [Letter to G. Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5360. Guildford Document Depository. UQ 33278.

Oldman M. Agro-Tobacco Services (ATS), Proposed Plan. November 1991. British American Tobacco Company. 502552655–2667 at 2659. Guildford Document Depository. UQ 33303.

INFOTAB International Workshop, Brussels, October 13-16, 1986. October 16, 1986. Philip Morris Companies Inc. 2501446636–7080 at 6723–6724. www.pmdocs.com UQ 33566.

Boca Raton Action Plan: Appendix A, WHOIIOCUIUICC: Strategies and Tactics. January 31, 1989. Philip Morris Companies Inc. 2501045143–5147.www.pmdocs.com UQ 32846.

Wells JK. INFOTAB Advisory Council Meeting July 14 and 15, 1982. July 21, 1982. Brown &Williamson Company. 680002301–2307.

Bliley Documents at www.tobaccodocuments.org. UQ 20.

Bible G. Corporate Affairs Conference I Action Plan. December 13, 1988. Philip Morris Companies Inc. 2021596422–6432 at 6429. www.pmdocs.com. UQ 32834.

Egawa E. April 25, 1986. Philip Morris Companies Inc. 2021654119–4123 at 4121. www.pmdocs.com. UQ 66.

Egawa E. April 25, 1986. Philip Morris Companies Inc. 2021654119–4123 at 4121. www.pmdocs.com. UQ 66.

INFOTAB International Workshop, Brussels, October 13-16, 1986. October 16, 1986. Philip Morris Companies Inc. 2501446636–7080 at 6677. www.pmdocs.com UQ 33566.

Egawa E. April 25, 1986. Philip Morris Companies Inc. 2021654119–4123 at 4120. www.pmdocs.com. UQ 66.

Whitley C. Statement of Charles O. Whitley on behalf of the Tobacco Institute before the Subcommittee on Health and the Environment, Committee on Energy and Commerce,  US House of Representatives [Draft]. July 9, 1990. Tobacco Institute TIMN 0032095–2141  at 2118. Bliley Documents. www.tobaccodocuments.org. UQ 32912.

Zhang M. [Attaching Press article in the China Daily on the CIAR’s GEP workshop in Guangzhou.] September 9, 1997. Philip Morris Companies Inc. 2063608546–8547. http://www.pmdocs.com. UQ 33752.

Whitley C. Statement of Charles O. Whitley on behalf of the Tobacco Institute before the Subcommittee on Health and the Environment, Committee on Energy and Commerce,  US House of Representatives [Draft]. July 9, 1990. Tobacco Institute TIMN 0032095–0032141 at 2118. Bliley Documents. www.tobaccodocuments.org. UQ 32912.

Press release by the organizers of the expert discussion of the “Physician’s View of Passive Smoking”: Health Danger through Passive Smoking Not Proven. April 1984. Philip Morris Companies. 1002965608–6509. www.pmdocs.com. UQ 33770.

Masironi R. [Letter to W. Kloepfer]. December 2, 1986. Philip Morris Companies Inc.

2025816621–6624. www.pmdocs.com. UQ 33771.

Greenberg D. IARC. September 15, 1993. Philip Morris Companies Inc. 2021184116–4121 at 4119. www.pmdocs.com. UQ 33590.

Walk, R.A. IARC Multi-Center Case Control Study of ETS and Lung Cancer, Your memo dated 21 May 93. July 13, 1993. Philip Morris Companies Inc. 2025493287. www.pmdocs.com. UQ 33616.

IARC Study. 1994est. Philip Morris Companies Inc. 2501347168–7173 at 7169. www.pmdocs.com. UQ 33595.

Pages R. IARC Study of ETS and Lung Cancer. May 21, 1993. Philip Morris Companies Inc. 2500015757. www.pmdocs.com. UQ 33617.

Walk, R.A. IARC Multi-Center Case Control Study of ETS and Lung Cancer: Update of information. July 30, 1993. Philip Morris Companies Inc. 2029041838–1839. http://www.pmdocs.com. UQ 33618.

Interview with Paolo Boffetta, April 17, 2000.

Greenberg D. IARC. September 15, 1993. Philip Morris Companies Inc. 2021184116–4121 at 4119. www.pmdocs.com. UQ 33590.

IARC Study. 1994est. Philip Morris Companies Inc. 2501347168–7173 at 7169. www.pmdocs.com. UQ 33595.

Greenberg D. IARC. September 15, 1993. Philip Morris Companies Inc. 2021184116–4121 at 4118. www.pmdocs.com. UQ 33590.

Boyse S. [Letter to Ron Tully.] April 18, 1990. British American Tobacco Company. 400099555. Guildford Document Depository. UQ 33507.

Boyse S. [Letter to PN Lee.] December 19, 1989. British American Tobacco Company. 400099679. Guildford Document Depository. UQ 33509.

Lee P. May 8, 1990. British American Tobacco Company. 502587275–7284 at 7275. Guildford Document Depository. UQ 33236.

Winokur M. [FAX to H. Reif attaching “CIAR and IARC, Next Steps and Options.”] December 19, 1994. Philip Morris Companies Inc. 2028381587–1588 at 1588. www.pmdocs.com. UQ 33746.

Interview with Paulo Boffetta, April 17, 2000.

Matthews R, MacDonald V. Passive smokers inhale six cigarettes a year. Sunday Telegraph. August 16, 1998.

Lyberopoulos, H. Presentation on IARC [enclosing overheads]. April 19, 1994. Philip Morris Companies Inc. 2501355931–5944 at 5942. www.pmdocs.com. UQ 33604.

Hockaday T, Cohen N. Thoughts on TASSC Europe. March 25, 1994. Philip Morris Companies Inc. 2025492898–2905 at 2899. http://www.pmdocs.com. UQ 33758.

Lindheim J. Presentation on Scientist Pro}ect. May 5, 1994. Philip Morris Companies Inc. 2025493201–3207 at 3205–3206. www.pmdocs.com. UQ 33708.

Ong E, Glantz S. Tobacco industry efforts subverting International Agency for Research on Cancer’s second–hand smoke study. The Lancet. 2000; 355: 1253–59.

www.esef.org.  March 2000.

www.esef.org.  March 2000.

www.esef.org.  March 2000.

Mooney L. Smoking out bad science. Wall Street J. March 19, 1998; A18.

Boffetta P, Agudo A, Ahrens W, et al. Multicenter case–control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst 1998; 90: 1440– 50.

Hirayama T. Non–smoking wives of heavy smokers have a higher risk of lung cancer: A study from Japan. BMJ 1981; 282:183–85.

Repace JL, Lowery AH. A quantitative estimate of nonsmokers’ lung cancer risk from passive smoking. Environment Int. 1985;11:3–22.

US Environmental Protection Agency. Health effects of passive smoking: Assessment of lung cancer in adults and respiratory disorders in children. Office of Research and Development, Office of Health and Environmental Assessment. EPA/600/6–90/006F, 1992b.

Boffetta P, Agudo A, Ahrens W, et al. Multicenter case–control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst 1998; 90: 1440–50.

British American Tobacco. [ News release]. March 5, 1998. Philip Morris Companies Inc. 2063594010–4240 at 4018. www.pmdocs.com. UQ 33750.

World Watch: Protecting our Global ‘Next Generation’-A Proposed Conference on Children’s Health Issues. October 1989. 300516227–6285 at 6235. Guildford Document Depository. UQ 33691.

World Watch: Protecting our Global ‘Next Generation’-A Proposed Conference on Children’s Health Issues. October 1989. British American Tobacco Company. 300516227–6285 at 6236. Guildford Document Depository. UQ 33691.

INFOTAB . Item 2 Report From The Secretary General . January 1, 1982est. Philip Morris Companies Inc. 2021594826–4836. www.pmdocs.com. UQ 32.

Background to the Structure and Operations of the Activist Movement. November 15, 1994.

Philip Morris Companies Inc. 2501110753– 0775. www.pmdocs.com. UQ 68.

Seymour M. 6 September 1996 IARC European Response Plan Workshop. August 8, 1996.

Philip Morris Companies Inc. 2063604476– 4498. www.pmdocs.com. UQ 71.

Hauser N. Trip Report-RomeIFAO November 26-29, 1984. November 26, 1984. Philip Morris

Companies Inc. 2023272592–2597. http://www.pmdocs.com. UQ 91.

Hoel D. Confidential-For Counsel Only. July 10, 1979. Brown & Williamson Company.

680040577–0579. Blilely Documents at www.tobaccodocuments.org. UQ 99.

Pages B. IARC. September 13, 1993. Philip Morris Companies Inc. 2029173981. www.pmdocs.com. UQ 32848.

Dietrich P. [Letter to Sharon Boyse]. October 8, 1991. British American Tobacco Company.

300516052–6053. Guildford Document Depository. UQ 32879.

Proctor C. WHO Meeting in Budapest. March 10, 1994. British American Tobacco Company.

  1. UQ 33214.

Ecoffey D. CASIN . British American Tobacco Company. 304002746–2749. Guildford Document Depository. UQ 33253.

Boyse S. 8th World Conference on Tobacco and Health. August 28, 1991. British American

Tobacco Company. 202019292–9293 at 9292. Guildford Document Depository. UQ 33262.

Tully R. 8th WCTH. January 29, 1992. British American Tobacco Company. 300504241– 4252. Guildford Document Depository. UQ 33334.

Global Business Forum. June 12, 1991. British American Tobacco Company. 300557205– 7210. Guildford Document Depository. UQ 33348.

CASIN. January 11, 1991. British American

Tobacco Company. 300557237–7259. Guildford Document Depository. UQ 33350.

Hartogh J. Report by Task Force 5th World Conference on Smoking and Health, Winnipeg, Canada, July 1983. February 26, 1981. Philip Morris Companies Inc. 2025049376–9377. www.pmdocs.com. UQ 33514.

The World Health Organization (WHO): Its Work Related to the Activities of the International Tobacco Industry. Philip Morris Companies Inc. 2501442830–2897 at 2501442889–2897. www.pmdocs.com. UQ 5.

Lojacono G. Research Group Informal Meeting On: Health Effects of ETS in Europe-Paris-P. Broussell Hospital (Ville}uif 13I14 March, 1991). March 1991est. Philip Morris Companies Inc. 2501356073–6076. www.pmdocs.com. UQ 33534.

JMH–possibly Hartogh J. Action Plan proposed by ICOSI Task Force 4th World Conference on Smoking & Health. January 29, 1979. Philip Morris Companies Inc. 2501015212–5215. www.pmdocs.com. UQ 33549.

The World Health Organization (WHO): Its Work Related to the Activities of the International Tobacco Industry. Philip Morris Companies Inc. 2501442830–2897 at 2834. www.pmdocs.com. UQ 5.

Tully R. 8th WCTH. January 29, 1992. British American Tobacco Company. 300504241– 4252. Guildford Document Depository. UQ 33334.

The World Health Organization (WHO): Its Work Related to the Activities of the International Tobacco Industry. Philip Morris Companies Inc. 2501442830–2897 at 2889– 2890. www.pmdocs.com. UQ 5.

Informal Meeting of the IARC Research Group on ETS and Human Cancer. Philip Morris Companies Inc. 2501349504–9507. http://www.pmdocs.com. UQ 33636.

47th WHO World Assembly:  Informal  meeting of some members of the IARC study group “ETS and the Lung Cancer”. Geneva May 3-6, 1994. Philip Morris Companies Inc. May 5, 1994.

2501347143–7144.  www.pmdocs.com. UQ 33637.

Wilhelmus J. WHO. April 18, 1995. Philip Morris Companies Inc. 2063625254. www.pmdocs.com. UQ 33541.

CECCM. IARC Study. April 4, 1995. British American Tobacco Company. 500804531– 4537. Guildford Document Depository. UQ 33774.

Cerioli A. Report on my attendance to the Conference “Conoscenze Scientifiche, Seperi Popolari e Socita Umana alle Soglie del Duemile. Attualite del Pensiero di A. Maccacaro.” January 27, 1997. Philip Morris

Companies Inc. 2502250796–0797. http://www.pmdocs.com. UQ 29.

Menchaca. January 25, 1990. British American Tobacco Company. 502587287. Guildford Document Depository. UQ 33237.

Lojacono G. Research Group Informal Meeting On: Health Effects of ETS in Europe-Paris-P. Broussell Hospital (Ville}uif 13I14 March, 1991). March 14, 1991est. Philip Morris

Companies Inc. 2501356073–6076. http://www.pmdocs.com. UQ 33534.

Pages R. [Forwarding note from H. Reif: IARC Study]. July 19, 1993. Philip Morris Companies Inc. 2025470098. www.pmdocs.com.  UQ 32800.

Dietrich P. [Letter to Sharon Boyse, Enclosing Memo of Visit to Thailand and Philippines]. January 29, 1992. British American Tobacco Company. 300516024–37. Guildford Document Depository. UQ 33682.

 

WHOIIOCUIUICC: Strategies and Tactics. January 31, 1989. Philip Morris Companies Inc. 2501045143–5147 at 5143. www.pmdocs.com. UQ 32846.

  1. Appendix I, INFOTAB January 1989 Discussion Paper. January 30, 1989. Philip Morris Companies Inc. 2501045258–5268 at 5262. pmdocs.com. UQ 33561.

  2. World Watch: Protecting our Global ‘Next Generation’-A Proposed Conference on Children’s Health Issues. October 1989. 300516227–6285 at 6235. Guildford Document Depository. UQ

  3. WHOIIOCUIUICC: Strategies and Tactics. January 31, 1989. Philip Morris Companies Inc. 2501045143–5147 at 5143. pmdocs.com. UQ 32846.

  4. Hartogh JM. To all members of the ICOSI task force 4th world conference on smoking and health. [Memo by E. Brueckner.] June 26, 1979. British American Tobacco Company. 100433043–3047 at 3046. Guildford Document Depository. UQ

  5. WHOIIOCUIUICC: Strategies and Tactics. January 31, 1989. Philip Morris Companies Inc. 2501045143–5147 at 5146. pmdocs.com. UQ 32846.

  6. Appendix I, INFOTAB January 1989 Discussion Paper. January 30, 1989. Philip Morris Companies Inc. 2501045258–5268. pmdocs.com. UQ 33561.

  7. WHOIIOCUIUICC: Strategies and

January 31,  1989. Philip Morris Companies  Inc.

.2501045143–5147  at  5146. www.pmdocs.com.

UQ 32846.

  1. PMI Corporate Affairs Action Plan 1990. November 2, 1989est. Philip Morris Companies Inc. 2500019979–9999 at 9980–9982. pmdocs.com. UQ 33558.

  2. Sullivan J. IARC Study. September 2, 1993. Philip Morris Companies Inc. 2501117793– 7797 at 7795. pmdocs.com. UQ 33603

  3. Egawa E. April 25, 1986. Philip Morris Companies Inc. 2021654119–4123. pmdocs.com. UQ 66.

  4. Bloxidge JA. International Tobacco Growers’ Association (ITGA). October 11, 1988. British American Tobacco Company. 502555415–5417 at 5417. Guildford Document Depository. UQ 33284.

  5. Boyse S. 8th World Conference on Tobacco and Health. August 28, 1991. British American Tobacco Company. 202019292–9293 at 9292. Guildford Document Depository. UQ

  6. Bible G. Corporate Affairs Conference I Action Plan. December 13, 1986. Philip Morris Companies Inc. 2021596422–6432 at 6429. pmdocs.com. UQ 32834.

  7. Appendix I, INFOTAB January 1989 Discussion Paper. January 30, 1989. Philip Morris Companies Inc. 2501045258–5268. pmdocs.com. UQ 33561.

  8. Interview with Alan Lopez, Coordinator, Epidemiology and Burden of Disease, World Health Organization, May 4,

  9. Oldman M. [Letter to G Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5363. Guildford Document Depository. UQ

  10. Agro-Tobacco Services-Programme Review No1. British American Tobacco Company. 502552606–2611 at 2609. Guildford Document Depository. UQ 33290.

  11. Interview with Alan Lopez, May 4,

  12. Lee PN. Helmut Schievelbein. August 9, 1979. Philip Morris Companies Inc. 2501159889–9891 at 9889. www.pmdocs.com. UQ 33717.

  13. Minutes of the Meeting of the Working Group of the E.E.C. Tobacco Manufacturers’ Associations, Held in Luxemburg on 4th and 5th October 1979. November 11, 1979. Philip Morris Companies Inc. 2501015083–5096 at 5088. pmdocs.com. UQ 33716.

  14. Belcher P. Scientific Committee on Tobacco and Health (SCTH). February 9, 1994. Rothmans International. Philip Morris Companies Inc. 2024188905–8907 at 8905. pmdocs.com. UQ 33715.

  15. Independent Scientific Review of the Toxic Substances Board Report, May 1989, Summary, Commissioned by the Tobacco Institute of New Zealand. 1989est. Philip Morris Companies Inc. 2504203558–3559. pmdocs.com. UQ 33535.

Collett C. Memo to Ted Sterling re: International Symposium on Environmental Tobacco Smoke, November 3-4, 1989.

November 1989est. Philip Morris Companies Inc. 2062856942. www.pmdocs.com. UQ 33536.

  1. Rothman’s International Tobacco ETS Workshop. May 1992est. Philip Morris Companies Inc. 2501237099. pmdocs.com. UQ 33532.

25 . Pen Pictures of Guest Speakers. May 1992est. Philip Morris Companies Inc. 2501237101– 7103 at 7101. www.pmdocs.com. UQ 33531.

  1. S&H. Re: Dr. Furst-Review of Non-Smoker Problem CTR Special Pro}ect. 1976est. Lorillard Tobacco Company. 03747419. TDO Supersite at tobaccodocuments.org. UQ 33714.

  2. From the record before Congress, the Case for Defeat of S. 772. 1983est. Tobacco Institute. TIMN 0353310–3320 at 3312. TDO Supersite at tobaccodocuments.org/. UQ 33729.

  3. Purvis A, Johnson J. Privileged and confidential attorneyIclient connumications. Trial Report, SummaryITestimonyIPro}ection. April 21, 1988. Philip Morris Companies Inc. 2025880540– 0543. Bliley Documents at tobaccodocuments.org. UQ 33730.

  4. Tobacco Institute Newsletter. March 12, 1982. Philip Morris Companies Inc. 515841024. Bliley Documents at tobaccodocuments.org. UQ 98.

Hoel D. Confidential-For counsel only. July 10, 1979. Philip Morris Companies Inc. 6267450002. Bliley Documents at www.tobaccodocuments.org.  UQ 99.

  1. Tobacco Institute Newsletter. March 12, 1982. Philip Morris Companies Inc. 515841024. Bliley Documents at tobaccodocuments.org. UQ 98.

  2. Lyberopoulos H. ARISE 1994-95 Activities and Funding. Philip Morris Companies Inc. 2024208096–8099. pmdocs.com. UQ 33779.

  3. Information on Associates for Research in Substance En}oyment Meeting in Venice. R.J. Reynolds Tobacco Company. 508300651–0667 at 0652. http://www.rjrtdocs UQ 33749.

  4. Wilhelmus J. WHO. April 18, 1995. Philip Morris Companies Inc. 2063625254. pmdocs.com. UQ 33541.

  5. Luik J, Snel J, Warburton D. ARISE (Associates for Research into the Science of En}oyment): A Summary of the Workshop Held in April 1995. April 1995est. R.J. Reynolds Tobacco Company.  511818234–8241. rjrtdocs.com. UQ 33731.

  6. The World Health Organization. December 1985est. Philip Morris Companies Inc. 2023267436. pmdocs.com. UQ 46.

36 . Reif H. Continuation of the Vettorazzi Pro}ect. March 25, 1992. Philip Morris Companies Inc. PM 2025594741–4743 at 4742. http://www.pmdocs.com. UQ 33466.

  1. Consultant to ICOSI on International Organisations. August 1980est. Philip Morris Companies Inc. 2025049734. pmdocs.com. UQ 37.

  2. Developing Countries Group (DCG). Progress report covering events since the ICOSI board of directors meeting October 5I8th,  1980. February 1981est. Philip Morris Companies Inc. 2025049364–9374 at 9365. pmdocs.com. UQ 40.

Hauser. [Letter to AG Leeks]. April 20, 1983. Philip Morris Companies Inc. 2023273908– 3909. www.pmdocs.com. UQ 42.

Secretariat Interim Report. December 28,1984. Philip Morris Companies Inc. 2023272512– 2617 at 2514. www.pmdocs.com. UQ 43.

  1. January 11, 1991. British American Tobacco Company. 300557237–7259 at 7241. Guildford Document Depository. UQ 33350.

  2. January 11, 1991. British American Tobacco Company. 300557237–7259 at 7240. Guildford Document Depository. UQ 33350.

  3. January 11, 1991. British American Tobacco Company. 300557237–7259 at 7256. Guildford Document Depository. UQ 33350.

  4. Interviews with Neil Collishaw, Leanne Riley, and Barbara Zolty, all former employees of the WHO’s Tobacco or Health Program, Feb. 4, 2000.

  5. Boca Raton Action Plan: WHOIIOCUIUICC: Strategies and Tactics. Philip Morris Companies Inc. 2501045143–5147 at 5146. pmdocs.com. UQ 32846.

  6. E–mail communication from Neil Collishaw. March 29,

  7. Interviews with Neil Collishaw, Barbara Zolty, and Leanne Riley, February 4,

  8. E–mail communication from Barbara Zolty, March 2,

  9. Sullivan J. IARC Study. September 2, 1993. Philip Morris Companies Inc. 2501117793– 7797 at 7795. pmdocs.com. UQ 33603.

  10. Von Maerestetten C. IARC. July 26, 1993. Philip Morris Companies Inc. 2025493295. pmdocs.com. UQ 33776.

  11. IARC Study. Philip Morris Companies Inc. 2501347168–7173 at 7172. pmdocs.com. UQ 33595.

Pages R. Update 2: IARC study of ETS and lung cancer. August 2, 1993. Philip Morris Companies  Inc. 20232999819. http://www.pmdocs.com.  UQ 33733.

  1. Memo on vaccines for world health organization. October 25, 1971. Philip Morris Companies Inc. 2012581044. pmdocs.com. UQ 4.

  2. Boca Raton Action Plan: WHOIIOCUIUICC: Strategies and Tactics. Philip Morris Companies Inc. 2501045143–5147 at 5146. pmdocs.com. UQ 32846.

  3. Flavor and Extract Manufacturers Association. Invoice. August 17, 1995. Philip Morris Companies Inc. 2050761274. pmdocs.com. UQ 33546.

  4. Schrankel K. Final Report to Contributors of Anethole Research Fund. August 25, 1998. Philip Morris Companies Inc. 2063597040. pmdocs.com. UQ 33548.

  5. Minutes of Anethole Task Force. May 2, 1996. Philip Morris Companies Inc. 2063616600. pmdocs.com. UQ 33547.

  6. Minutes of Anethole Task Force. May 2, 1996. Philip Morris Companies Inc. 2063616600. pmdocs.com. UQ 33547.

Schrankel. Final Report to Contributors of Anethole Research Fund. August 25, 1998. Philip Morris Companies Inc. 2063597040. www.pmdocs.com. UQ 33548 TIMN270055–0059 at 0058. http://www.tobaccoinstitute.com. UQ 32904.

Hartogh JM. To all members of the ICOSI task force 4th world conference on smoking and health. [Memo by E. Brueckner.] June 26, 1979. British American Tobacco Company. 100433043–3047. Guildford Document Depository. UQ 33162.

Oldman M. [Letter to G Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5358. Guildford Document Depository. UQ 33278.

Companies Inc. 2025049727–9733 at 9728.

56.

Temple B. Re: ICD Meeting-4 October 1991.

www.pmdocs.com. UQ 39.

September 13, 1991. British  American Tobacco                 61. Developing Countries Ad Hoc Group (DCG).

57.

Company. 300516087–6090. UQ 33573.

Temple B. Industry Council for Development

Progress Report Covering Events  Since the

ICOSI Board of  Directors Meeting October

(ICD). May 1, 1991. British American Tobacco Company. 300516092–6095 at 6092–6093.

Guildford Document Depository. UQ 33781.

5I8th 1980. February 1981est. Philip Morris Companies Inc. 2025049364–9374 at 9368–

9369. www.pmdocs.com. UQ 40.

58.

Finnegan T, Senkus M, Zahn L.

Action Plan proposed by ICOSI Task Force on 4th World Conference On Smoking & Health Stockholm, June 18-22,1979. January 30, 1979. Council for Tobacco Research. 10395689–5695.

62.

Observations on the Fifth World Conference on Smoking and Health by  a  Consultant, Winnipeg, July 1983.  July 1983est. Philip Morris Companies Inc. 2501021685–1709 at 1685. www.pmdocs.com. UQ 32890.

59.

http://www.ctr–usa.org/ctr. UQ 32797.

Secretariat interim report. December 28, 1984.

63.

Observations on the Fifth World Conference on Smoking and Health by a Consultant,

Philip Morris Companies Inc. 2023272512. com. UQ 43.

Winnipeg, July 1983. July 1983est. Philip Morris Companies Inc. 2501021685–1709 at

Marcotullio RJ. INFOTAB Board of Director’s (BOD) Meeting-London, March 30, 1981. April

64.

1688. www.pmdocs.com. UQ 32890.

INFOTAB . Item 2, Report From The Secretary

6, 1981. 502741855–1859. Bliley Documents at

www.tobaccodocuments.org. UQ 60.

General . January 1982est. Philip Morris Companies Inc. 2021594826–4836 at 4833.

Witt S. International Committee on Smoking Issues Lausanne-November 10-12, 1977.

www.pmdocs.com. UQ 32.

Hauser N. Trip Report-RomeIFAO November

November 18, 1977. 502330543–0563 at 0556–

0557. Bliley Documents at www.tobaccodocuments.org. UQ 61.

26-29, 1984. November 26, 1984. Philip Morris

Companies Inc. 2023272592–2597.

www.pmdocs.com. UQ 91.

Ely B. Infotab Board Meeting 30th and 31st October, 1983. November 18, 1983. Brown & Williamson Tobacco Company. 680404650.

Developing Countries Strategy Group. January 1985est. Philip Morris Companies Inc.

2025013364. www.pmdocs.com. UQ 32892.

www.bwdocs.aalatg.com. UQ 32824.

Vogel C. Minutes of the Kansas City Sub

Corti A. Director of Information Services, INFOTAB. Latin American Meetings-

Group. December 7, 1978. Tobacco Institute.

GenevaIRome, March 9-15, 1987. January 15,

  1. Developing Countries Ad Hoc Group (DCG). Progress Report Covering Events Since the ICOSI Board of Directors Meeting on 19th February, 1980. August 1980est. Philip Morris 1987. British American Tobacco Company. 301760973–0979 at 0979. Guildford Document Depository. UQ 33254

Appendix I, INFOTAB January 1989, Discussion Paper. January 30, 1989. Philip Morris Companies Inc. 2501045258–5268 at 5262. Minnesota Document Depository. UQ 33561.

  1. Pro}ect Report Covering Pro}ects and Action Plans Since the Board of Directors Meeting on March 30, 1981. 1981est. Philip Morris Companies Inc. 2025048077–8088 at 8077. pmdocs.com. UQ 41.

  2. Pro}ect Report Covering Pro}ects and Action Plans Since the Board of Directors Meeting on March 30, 1981. Philip Morris Companies Inc. 2025048077–8088 at 8082. www.pmdocs.com. UQ 41.

  3. Verkerk H. Fifth World Conference on Smoking and Health-Winnepeg. Philip  Morris Companies Inc. 2501021564–1586 at 1577. pmdocs.com. UQ 32888.

  4. Secretariat Interim Report. December 28, 1984. Philip Morris Companies Inc. 2023272512– 2617 at 2594. pmdocs.com. UQ 43.

  5. INFOTAB Board of Director’s (BOD) Meeting-March 30, 1981. April 6, 1981. 502741855. Bliley Documents at www.tobaccodocuments.org. UQ 60.

Witt S. International Committee on Smoking Issues Lausanne-November 10-12, 1977.

November 18, 1977. 502330545. Bliley Documents at www.tobaccodocuments.org. UQ 61.

Schlosser A, Mine K (Chadbourne, Parke). Representative Compilation of Literature Describing the Benefits of Tobacco. April 29, 1986. Brown & Williamson Company.

681870460–0654 at 0602. Bliley Documents at

www.tobaccodocuments.org.  UQ 64.

INFOTAB. INFOTAB Workshop. Undated. Philip Morris Companies Inc. 2501021710– 1711. www.pmdocs.com. UQ 32891.

  1. April 20, 1983. Philip Morris Companies Inc. 2023273908. www.pmdocs.com. UQ 42.

  2. Secretariat Interim Report. December 28, 1984. Philip Morris Companies Inc. 2023272512– 2617 at 2594. pmdocs.com. UQ 43.

Simpson B, Hauser N. Background Papers for the INFOTAB Advisory Group Meeting, December, 5-7, 1983. November 25, 1983.

Brown & Williamson Tobacco Company. 699101438–1473. www.bwdocs.aalatg.com.

UQ 32853.

  1. International Organizations Monitoring Service. Industry Sectors and International Organizations-Tobacco Update and Outlook on World Health Organization Activities Affecting MNCs. March 5, 1986. Philip  Morris Companies Inc. 2024272808- 2814 at 2812. Bliley Documents at tobaccodocuments.org. UQ 33777.

  2. Oldman M. [Letter to D. Bacon, enclosing “Agro-Tobacco Services (ATS), Proposal for a Consultancy Agreement”]. January 7, 1992. British American Tobacco Company. 502552644–2654 at 2650. Guildford Document Depository. UQ

  3. Oldman M. [Letter to D. Bacon, enclosing “Agro-Tobacco Services (ATS), Proposal for a Consultancy Agreement”]. January 7, 1992. British American Tobacco Company. 502552644–2654 at 2647. Guildford Document Depository. UQ

  4. Oldman M. [Letter to G. Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5361. Guildford Document Depository. UQ

  5. Oldman M. [Letter to G. Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5358. Guildford Document Depository. UQ

  6. Oldman M. [Letter to G. Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5361. Guildford Document Depository. UQ

  7. Oldman M. [Letter to D Bacon enclosing Agro- tobacco Activity Report for January 1993]. February 10, 1993. British American Tobacco Company. 502552508–2513 at 2512–2513. Guildford Document Depository. UQ

  8. Oldman M. Paper for ITGA General Meeting, 1994. British American Tobacco

80.

Company. 502552280–2293 at 2288. Guildford Document Depository. UQ 33286.

Opukah S. ECOSOCIFAO Positions on Tobacco. August 18, 1994. British American

88.

89.

Brady B. March 3, 1992. British American Tobacco Company. 202049846–9847 at 9847. Guildford Document Depository. UQ 33255.

Brady B. March 3, 1992. British American

Tobacco Company. 502570804. Guildford

Tobacco Company. 202049846–9847 at 9847.

Document Depository. UQ 33304.

Guildford Document Depository. UQ 33255.

81.

May R. The World Bank Position Towards Tobacco. October 17, 1992. Philip Morris

90.

Hartley R. [Note to Mr. B.D. Bramley].June 28, 1993. British American Tobacco Company.

Companies Inc. 2028464078.

502587026–7027 at 7026. Guildford Document

www.pmdocs.com. UQ 32864.

Depository. UQ 33230.

Oldman M. [Letter to D. Bacon enclosing “Some Thoughts on the Future Management of the Industry’s Agro-Tobacco Programme”].

March 29, 1995. British American Tobacco

91.

Oldman M. [FAX to D. Bacon enclosing “Some Thoughts on the Future Management of the Industry’s Agro-Tobacco Programme”]. March

29, 1995. British American Tobacco Company.

Company. 502555220–5226 at 5522. Guildford

502555220–5226 at 5522. Guildford Document

Document Depository. UQ 33269.

Depository. UQ 33269.

Oldman M. [Letter to D. Bacon enclosing

activity Report for June]. July 3, 1992. British American Tobacco Company. 502552616–2620

92.

Oldman M. [FAX to D. Bacon enclosing “Some

Thoughts on the Future Management of the Industry’s Agro-Tobacco Programme”]. March

at 2617. Guildford Document Depository. UQ

29, 1995. British American Tobacco Company.

33299.

502555220–5226. Guildford Document

82.

INFOTAB . Item 2, Report From The Secretary General . January 1, 1982est. Philip Morris

93.

Depository. UQ 33269.

Bacon D. Development Aid, Progress.

Companies Inc. 2021594826–4836 at 4827.

November 28, 1991. British American Tobacco

www.pmdocs.com. UQ 32.

Company. 202049931–9932 at 9932. Guildford

83.

Industry Sectors and International Organizations-Tobacco Update and Outlook on

94.

Document Depository. UQ 33256.

The 1995 Agro-Tobacco Programme,

World Health Organization Activities Affecting

MNCs. March 5, 1986. Philip Morris

Proposals for Discussion. 1994est. British

American Tobacco Company. 502552341–2343

Companies Inc. 2024272808–8014 at 8012.

at 2341. Guildford Document Depository. UQ

Bliley Documents at

33288.

84.

www.tobaccodocuments.org. UQ 51.

Honour H. September 11, 1991. British

95.

Oldman M. Paper for ITGA General Meeting, 1994. 1994est. British American Tobacco

American Tobacco Company. 202049970–9973

Company. 502552280–2293 at 2289. Guildford

at 9971. Guildford Document Depository. UQ

Document Depository. UQ 33286.

85.

33257.

Bacon D. Development Aid, Progress.

96.

The ITGA 1996 Work Programme. Tobacco Courier. December 1, 1995est. British American

November 28, 1991. British American Tobacco

Tobacco Company. 601030389–0413 at 0395.

Company. 202049931–9932 at 9931. Guildford

Guildford Document Depository. UQ 33319.

Document Depository. UQ 33256.

  1. Bacon D. Development Aid, Progress. November 28, 1991. British American Tobacco Company. 202049931–9932 at 9931. Guildford Document Depository. UQ

  2. Bacon D. Development Aid, Progress. November 28, 1991. British American Tobacco Company. 202049931–9932 at 9932. Guildford Document Depository. UQ

  3. Interview with Neil Collishaw, Feb. 4,

  4. Bible G. Corporate Affairs Conference I Action Plan. December 13, 1988. Philip Morris Companies Inc. 2021596422–6432 at 6429. pmdocs.com. UQ 32834.

Boca Raton Action Plan: Status Report for the Period Ending January 31, 1989. January 31, 1989. Philip Morris Companies Inc.2500103969–4056 at 3989. www.pmdocs.com.

UQ 32863.

  1. Boyse S. [Letter to Peter Hazel, David Bacon, and JJ Mostyn]. August 8, 1991. British American Tobacco Company. 304004032. Guildford Document Depository. UQ 33184

  2. Dietrich P. WHO spends money on what? The Wall Street Journal, May 9, 1989. UQ

  3. Oldman M. [Letter to D. Bacon enclosing Activity Report, September/October 1993]. November 1, 1993. British American Tobacco Company. 502555329–5331 at 5331. UQ 33276.

Boca Raton Action Plan: Status Report for the Period Ending May 31, 1989. May 31, 1989. Philip Morris Companies Inc. 2021592752– 2764 at 2752. www.pmdocs.com. UQ 32859.

  1. Boca Raton Action Plan: Status Report Ending July 31, 1989. July 31, 1989. Philip Morris Companies Inc. 2023547120–7135 at 7121. pmdocs.com. UQ 32860.

  2. Boca Raton Action Plan Summary Report December 3, 1988-October 30, 1989. October 30, 1989. Philip Morris Companies Inc. 2503005015–5050. pmdocs.com. UQ 32862.

Oldman M. [Letter to D. Bacon enclosing Activity Report, September/October 1993]. November 1, 1993. British American Tobacco Company. 502555329–5331 at 5331. UQ 33276

  1. Ntaba H. Letter to the Editor, International Health and Development, Vol. 1, No. 2, Summer, p. 31. UQ

  2. Boca Raton Action Plan: Status Report for the Period Ending September 30, 1989. September 30, 1989. Philip Morris Companies Inc. 2501204997–5021 at 4998. pmdocs.com. UQ 32861.

  3. Boyse S. [Letter to Paul Dietrich]. August 7, 1991. British American Tobacco Company. 300516113. Guildford Document Depository. UQ

  4. Rupp J. Statement, Philip Morris International (Latin America). November 30, 1992. Philip Morris Companies Inc. 2023591405. pmdocs.com. UQ 32903.

Bacon D. Who Benefits from WHO? November 24, 1993. British American Tobacco Company.

  1. UQ 33311.

  2. Agenda: “Primer Encuentro de Periodistas Y la Industria Del Tabaco.” June 1991est. British American Tobacco Company. 300565679– 5681. Guildford Document Depository. UQ 33675.

BAT Smoking Issues Briefing, Taiwan. September 6–8, 1992. British American

Tobacco Company. 300565674–5675. Guildford Document Depository. UQ 33677.

Agenda, Meeting of Social Communicators and the Tobacco Industry. November 1992est.

British American Tobacco Company. 300565668–5671. Guildford Document Depository. UQ 33678.

  1. Oldman M. [Letter to G. Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5359. Guildford Document Depository. UQ

  2. Bloxidge JA. International Tobacco Growers’ Association (ITGA). October 11, 1988. British American Tobacco Company. 502555415– 5417. Guildford Document Depository. UQ 33284.

  3. Oldman M. [Letter to G. Pedlow]. March 13, 1991. British American Tobacco Company. 502555357–5363 at 5360. Guildford Document Depository. UQ

  4. Oldman M. Agro-Tobacco Services (ATS), Proposed Plan. November 1991. British American Tobacco Company. 502552655–2667 at 2659. Guildford Document Depository. UQ 33303.

  5. INFOTAB International Workshop, Brussels, October 13-16, 1986. October 16, 1986. Philip Morris Companies Inc. 2501446636–7080 at 6723–6724. pmdocs.com UQ 33566.

  6. Boca Raton Action Plan: Appendix A, WHOIIOCUIUICC: Strategies and Tactics. January 31, 1989. Philip Morris Companies Inc. 2501045143–5147.pmdocs.com UQ 32846.

  7. Wells JK. INFOTAB Advisory Council Meeting July 14 and 15, 1982. July 21, 1982. Brown &Williamson Company. 680002301–2307.

Bliley Documents at www.tobaccodocuments.org. UQ 20.

  1. Bible G. Corporate Affairs Conference I Action Plan. December 13, 1988. Philip Morris Companies Inc. 2021596422–6432 at 6429. pmdocs.com. UQ 32834.

  2. Egawa E. April 25, 1986. Philip Morris Companies Inc. 2021654119–4123 at 4121. pmdocs.com. UQ 66.

  3. Egawa E. April 25, 1986. Philip Morris Companies Inc. 2021654119–4123 at 4121. pmdocs.com. UQ 66.

  4. INFOTAB International Workshop, Brussels, October 13-16, 1986. October 16, 1986. Philip Morris Companies Inc. 2501446636–7080 at 6677. pmdocs.com UQ 33566.

  5. Egawa E. April 25, 1986. Philip Morris Companies Inc. 2021654119–4123 at 4120. pmdocs.com. UQ 66.

  6. Whitley C. Statement of Charles O. Whitley on behalf of the Tobacco Institute before the Subcommittee on Health and the Environment, Committee on Energy and Commerce, US House of Representatives [Draft]. July 9, 1990. Tobacco Institute TIMN 0032095–2141  at 2118. Bliley Documents. tobaccodocuments.org. UQ 32912.

Zhang M. [Attaching Press article in the China Daily on the CIAR’s GEP workshop in Guangzhou.] September 9, 1997. Philip Morris Companies Inc. 2063608546–8547. http://www.pmdocs.com. UQ 33752.

  1. Whitley C. Statement of Charles O. Whitley on behalf of the Tobacco Institute before the Subcommittee on Health and the Environment, Committee on Energy and Commerce, US House of Representatives [Draft]. July 9, 1990. Tobacco Institute TIMN 0032095–0032141 at 2118. Bliley Documents. tobaccodocuments.org. UQ 32912.

  2. Press release by the organizers of the expert discussion of the “Physician’s View of Passive Smoking”: Health Danger through Passive Smoking Not Proven. April 1984. Philip Morris Companies. 1002965608–6509. pmdocs.com. UQ 33770.

Masironi R. [Letter to W. Kloepfer]. December 2, 1986. Philip Morris Companies Inc. 2025816621–6624. www.pmdocs.com. UQ 33771.

  1. Greenberg D. September 15, 1993. Philip Morris Companies Inc. 2021184116–4121 at 4119. www.pmdocs.com. UQ 33590.

  2. Walk, R.A. IARC Multi-Center Case Control Study of ETS and Lung Cancer, Your memo dated 21 May 93. July 13, 1993. Philip Morris Companies Inc. 2025493287. pmdocs.com. UQ 33616.

  3. IARC Study. 1994est. Philip Morris Companies Inc. 2501347168–7173 at 7169. pmdocs.com. UQ 33595.

Pages R. IARC Study of ETS and Lung Cancer. May 21, 1993. Philip Morris Companies Inc. 2500015757. www.pmdocs.com. UQ 33617.

Walk, R.A. IARC Multi-Center Case Control Study of ETS and Lung Cancer: Update of information. July 30, 1993. Philip Morris Companies Inc. 2029041838–1839. http://www.pmdocs.com. UQ 33618.

  1. Interview with Paolo Boffetta, April 17, 2000.

  2. Greenberg D. September 15, 1993. Philip Morris Companies Inc. 2021184116–4121 at 4119. www.pmdocs.com. UQ 33590.

  3. IARC Study. Philip Morris Companies Inc. 2501347168–7173 at 7169. www.pmdocs.com. UQ 33595.

  4. Greenberg D. September 15, 1993. Philip Morris Companies Inc. 2021184116–4121 at 4118. www.pmdocs.com. UQ 33590.

  5. Boyse S. [Letter to Ron Tully.] April 18, 1990. British American Tobacco Company. 400099555. Guildford Document Depository. UQ

Boyse S. [Letter to PN Lee.] December 19, 1989. British American Tobacco Company. 400099679. Guildford Document Depository. UQ 33509.

  1. Lee P. May 8, 1990. British American Tobacco Company. 502587275–7284 at 7275. Guildford Document Depository. UQ

  2. Winokur M. [FAX to H. Reif attaching “CIAR and IARC, Next Steps and Options.”] December 19, 1994. Philip Morris Companies Inc. 2028381587–1588 at 1588. pmdocs.com. UQ 33746.

  1. Interview with Paulo Boffetta, April 17,

  2. Matthews R, MacDonald V. Passive smokers inhale six cigarettes a year. Sunday Telegraph. August 16,

  3. Lyberopoulos, H. Presentation on IARC [enclosing overheads]. April 19, 1994. Philip Morris Companies Inc. 2501355931–5944 at 5942. pmdocs.com. UQ 33604.

Hockaday T, Cohen N. Thoughts on TASSC Europe. March 25, 1994. Philip Morris

Companies Inc. 2025492898–2905 at 2899. http://www.pmdocs.com. UQ 33758.

  1. Lindheim J. Presentation on Scientist Pro}ect. May 5, 1994. Philip Morris Companies Inc. 2025493201–3207 at 3205–3206. pmdocs.com. UQ 33708.

  2. Ong E, Glantz S. Tobacco industry efforts subverting International Agency for Research on Cancer’s second–hand smoke study. The Lancet. 2000; 355: 1253–59.

  3. esef.org. March 2000.

  4. esef.org. March 2000.

  5. esef.org. March 2000.

  6. Mooney L. Smoking out bad science. Wall Street J. March 19, 1998;

  7. Boffetta P, Agudo A, Ahrens W, et al. Multicenter case–control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst 1998; 90: 1440– 50.

  8. Hirayama T. Non–smoking wives of heavy smokers have a higher risk of lung cancer: A study from Japan. BMJ 1981; 282:183–85.

Repace JL, Lowery AH. A quantitative estimate of nonsmokers’ lung cancer risk from passive smoking. Environment Int. 1985;11:3–22.

US Environmental Protection Agency. Health effects of passive smoking: Assessment of lung cancer in adults and respiratory disorders in children. Office of Research and Development, Office of Health and Environmental Assessment. EPA/600/6–90/006F, 1992b.

  1. Boffetta P, Agudo A, Ahrens W, et al. Multicenter case–control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst 1998; 90: 1440–50.

  2. British American Tobacco. [ News release]. March 5, 1998. Philip Morris Companies Inc. 2063594010–4240 at 4018. pmdocs.com. UQ 33750.

  3. World Watch: Protecting our Global ‘Next Generation’-A Proposed Conference on Children’s Health Issues. October 1989. 300516227–6285 at 6235. Guildford Document Depository. UQ

  4. World Watch: Protecting our Global ‘Next Generation’-A Proposed Conference on Children’s Health Issues. October 1989. British American Tobacco Company. 300516227–6285 at 6236. Guildford Document Depository. UQ 33691.

  5. INFOTAB . Item 2 Report From The Secretary General . January 1, 1982est. Philip Morris Companies Inc. 2021594826–4836. pmdocs.com. UQ 32.

Background to the Structure and Operations of the Activist Movement. November 15, 1994.

Philip Morris Companies Inc. 2501110753– 0775. www.pmdocs.com. UQ 68.

Seymour M. 6 September 1996 IARC European Response Plan Workshop. August 8, 1996.

Philip Morris Companies Inc. 2063604476– 4498. www.pmdocs.com. UQ 71.

Hauser N. Trip Report-RomeIFAO November 26-29, 1984. November 26, 1984. Philip Morris

Companies Inc. 2023272592–2597.

www.pmdocs.com. UQ 91.

Hoel D. Confidential-For Counsel Only. July 10, 1979. Brown & Williamson Company.

680040577–0579. Blilely Documents at www.tobaccodocuments.org. UQ 99.

Pages B. IARC. September 13, 1993. Philip Morris Companies Inc. 2029173981. www.pmdocs.com. UQ 32848.

Dietrich P. [Letter to Sharon Boyse]. October 8, 1991. British American Tobacco Company.

300516052–6053. Guildford Document

Depository. UQ 32879.

Proctor C. WHO Meeting in Budapest. March 10, 1994. British American Tobacco Company.

  1. UQ 33214.

Ecoffey D. CASIN . British American Tobacco Company. 304002746–2749. Guildford Document Depository. UQ 33253.

Boyse S. 8th World Conference on Tobacco and Health. August 28, 1991. British American

Tobacco Company. 202019292–9293 at 9292. Guildford Document Depository. UQ 33262.

Tully R. 8th WCTH. January 29, 1992. British American Tobacco Company. 300504241– 4252. Guildford Document Depository. UQ 33334.

Global Business Forum. June 12, 1991. British American Tobacco Company. 300557205– 7210. Guildford Document Depository. UQ 33348.

CASIN. January 11, 1991. British American

Tobacco Company. 300557237–7259. Guildford Document Depository. UQ 33350.

Hartogh J. Report by Task Force 5th World Conference on Smoking and Health, Winnipeg, Canada, July 1983. February 26, 1981. Philip Morris Companies Inc. 2025049376–9377. www.pmdocs.com. UQ 33514.

  1. The World Health Organization (WHO): Its Work Related to the Activities of the International Tobacco Industry. Philip Morris Companies Inc. 2501442830–2897 at 2501442889–2897. pmdocs.com. UQ 5.

Lojacono G. Research Group Informal Meeting On: Health Effects of ETS in Europe-Paris-P. Broussell Hospital (Ville}uif 13I14 March, 1991). March 1991est. Philip Morris Companies Inc. 2501356073–6076. www.pmdocs.com. UQ 33534.

JMH–possibly Hartogh J. Action Plan proposed by ICOSI Task Force 4th World Conference on Smoking & Health. January 29, 1979. Philip Morris Companies Inc. 2501015212–5215. www.pmdocs.com. UQ 33549.

  1. The World Health Organization (WHO): Its Work Related to the Activities of the International Tobacco Industry. Philip Morris Companies Inc. 2501442830–2897 at 2834. pmdocs.com. UQ 5.

Tully R. 8th WCTH. January 29, 1992. British American Tobacco Company. 300504241– 4252. Guildford Document Depository. UQ 33334.

  1. The World Health Organization (WHO): Its Work Related to the Activities of the International Tobacco Industry. Philip Morris Companies Inc. 2501442830–2897 at 2889– 2890. pmdocs.com. UQ 5.

Informal Meeting of the IARC Research Group on ETS and Human Cancer. Philip Morris Companies Inc. 2501349504–9507.

www.pmdocs.com. UQ 33636.

47th WHO World Assembly:  Informal  meeting of some members of the IARC study group “ETS and the Lung Cancer”. Geneva May 3-6, 1994. Philip Morris Companies Inc. May 5, 1994.

2501347143–7144.  www.pmdocs.com. UQ

33637.

Wilhelmus J. WHO. April 18, 1995. Philip Morris Companies Inc. 2063625254. www.pmdocs.com. UQ 33541.

CECCM. IARC Study. April 4, 1995. British American Tobacco Company. 500804531– 4537. Guildford Document Depository. UQ 33774.

Cerioli A. Report on my attendance to the Conference “Conoscenze Scientifiche, Seperi Popolari e Socita Umana alle Soglie del Duemile. Attualite del Pensiero di A. Maccacaro.” January 27, 1997. Philip Morris

Companies Inc. 2502250796–0797.

www.pmdocs.com. UQ 29.

Menchaca. January 25, 1990. British American Tobacco Company. 502587287. Guildford Document Depository. UQ 33237.

Lojacono G. Research Group Informal Meeting On: Health Effects of ETS in Europe-Paris-P. Broussell Hospital (Ville}uif 13I14 March, 1991). March 14, 1991est. Philip Morris

Companies Inc. 2501356073–6076.

www.pmdocs.com. UQ 33534.

Pages R. [Forwarding note from H. Reif: IARC Study]. July 19, 1993. Philip Morris Companies Inc. 2025470098. www.pmdocs.com.  UQ 32800.

Dietrich P. [Letter to Sharon Boyse, Enclosing Memo of Visit to Thailand and Philippines]. January 29, 1992. British American Tobacco Company. 300516024–37. Guildford Document Depository. UQ 33682.

 

 

 


by Leave a comment

Smoking & Health – Fake Science Kills

What if every scientific study on cigarettes, smoking and health run by the tobacco industry and all of the “data” that has emerged over the past 50 years is severely compromised at the deepest levels?

What if most or all of the data the tobacco industry has been generating continuously to support its claims is fundamentally compromised by flawed research protocols and methodologies, contaminated research materials, inexplicable oversights, and good old-fashioned deceptive practices? What if all this can be directly linked to a single, underlying,’Achilles Heel’ flaw that can be easily verified?

What would that imply for regulations on tobacco products, for anti-tobacco legislation, for treaties and international agreements, for health care and insurance policies, for victims and juries, and for generations of legal decisions and precedent – if all were based on flawed science?

It is.

The core assumption of virtually all smoking & health research is that it is studying tobacco and only tobacco.

A corollary assumption is that cigarettes are tobacco and that cigarette smoke is tobacco smoke.

So when cigarette smoke is generated for research purposes, the assumption is that the smoke being studied is tobacco smoke or, if that assumption is ever questioned, its functional equivalent.

It’s not.

Virtually every research study on smoking and health run by the tobacco industry and its worldwide network of scientists and doctors since the 1970’s is based on the use of University of Kentucky standard “Reference Cigarettes”. Most or possibly all of the data derived using these standard Reference Cigarettes, which are used worldwide in virtually all tobacco industry studies involving cigarettes, are compromised and must be re-evaluated.

There are four main reasons why I believe that tobacco industry standard Reference Cigarettes consistently produce false and misleading data.

  1. There is non-random selection bias in the commercially-sourced leaf tobacco components of Reference Cigarettes.

Explanation

The tobacco leaf used in production of Reference Cigarettes is “commercially-sourced”, and is a non-random sample of the commercially tobacco types available at the time of the manufacturing run. Reference cigarette manufacturers, working to published industry standards, simply use whatever Flue-Cured, Burley, Maryland and Oriental tobacco leaf is convenient for a particular run of Reference Cigarettes. (It’s unclear whether there is more than one manufacturer for a run of reference cigarettes.) The Flue-Cured, for example, could be from North Carolina or Brazil or Zimbabwe. As long as it’s “Flue-Cured”, it meets tobacco industry scientific research standards and no other selection standards or procedures are specified by the certifying body for the tobacco industry. This means there is significant potential variability between the “Flue-Cured” selected for manufacturing into a run of Reference Cigarettes and the Flue-Cured that another manufacturer might use in their cigarette production. The same is true for all tobacco types selected and used in Reference Cigarettes.

  1. There is uncontrolled and unacknowledged variability in the “sheet tobacco” components of Reference Cigarettes.

Explanation

Tobacco Sheet is manufactured from tobacco waste, stems and scrap of variable, multiple, indeterminate foreign and domestic origins, and includes non-tobacco constituents that also vary depending on the “sheet” or “recon” tobacco manufacturing process used. Tobacco sheet is a 20-25% component of Reference Cigarettes. Millions of pounds of foreign-sourced tobacco waste is imported into the US annually for the specific purpose of “tobacco sheet” manufacturing by multiple manufacturers in multiple factories using multiple processing methods. Yet the industry standards for Reference Cigarette manufacturing don’t acknowledge this critical source of variability in the components of Reference Cigarettes, the reference standard for all industry-sponsored cigarette testing worldwide. The highly variable nature of a 20-25% component of all Reference Cigarettes seems sufficient in itself to invalidate data based on the use of Reference Cigarettes. Further, some of the Reference Cigarette recon is standard recon and some is “Sweitzer method” recon, and the two processes are not equivalent.

Finally, there’s variation in tobacco itself. “Tobacco is not a homogeneous product. The flavor, mildness, texture, tar, nicotine, and sugar content vary considerably across varieties or types of tobacco. Defining characteristics of different tobacco types include the curing process (flue-, air-, sun-cured) and leaf color (light or dark), size, and thickness. A given type of tobacco has a different quality depending on where it is grown, its position on the stalk (leaves near the bottom of the stalk are lower in quality), and weather conditions during growing and curing.” (from Tobacco and the Economy , USDA)

  1. There are known but not included in analysis, highly variable concentrations of agrichemical and pesticide residues on the leaf tobacco component and in the sheet tobacco component of Reference Cigarettes. 

Explanation 

Tobacco leaf, sheet, waste and scrap all carry a burden of biologically active pesticides that are not on the industry list of “toxicants” tested for in standardizing the Reference Cigarettes. Extensive research literature establishes the widespread presence of pesticide residues on commercially-sourced tobacco and tobacco waste. When testing is performed on cigarette smoke using the Reference Cigarettes as a baseline or standard, the measured smoke stream constituents will be the byproducts of the interaction of recognized, known and acknowledged tobacco constituents along with an undetermined number and concentration of unknown pesticides whose common presence on commercial, and especially on imported tobacco is well-established. There is no way to tell how the measured ‘toxicants’ in any sets of results using Reference Cigarettes have been affected by combustion of pesticide residues because the tobacco being used is not tested for the presence or concentration of those residues. Because of this error in research design, any smoke stream ‘toxicant’ data based on Reference Cigarettes will be flawed in unpredictable ways and should not be accepted without re-evaluation.

  1. The tobacco leaf used for manufacturing Reference Cigarettes is sourced from standard unsegregated commercial markets for Flue-Cured, Maryland, Oriental, and Burley tobacco leaf.

Explanation

Commercially sourced tobacco is, unless otherwise specified, an aggregated universe of tobacco leaf grown and handled under a wide range of environmental and agronomic conditions. Only tobacco leaf grown domestically under controlled conditions and kept separate from commercial tobacco could be used as to produce a reference cigarette that would be uniform enough in biochemical makeup to legitimately serve as a universal standard. A large proportion of the Flue-Cured and Maryland, and nearly all the Oriental Tobacco in the commercial market at any given time is from foreign sources. This means that the Reference Cigarette manufacturers who simply source by category have no idea where any given batch of leaf comes from or what its biological parameters might be aside from any commercial sampling or batch testing testing they may or may not do. As a result there simply can’t be uniformity or standardization of important parameters of the biological makeup of the tobacco plant materials used in manufacturing Reference Cigarettes.

So that’s it. Well, actually there a whole lot more, supported by reams of references all from peer-reviewed sources. But for now I thought I would just lay this out as clearly and simply as possible and see if anyone cares that the tobacco industry has been creating fake science for 50 years now and they have never really been called on it much less held accountable in meaningful ways.

The “Tobacco Settlement”, for example, is a horrible joke and a legal travesty but it is based on what can be shown to be such deliberately bad science and deceptively derived evidence that the whole issue of liability and intent on the part of the Tobacco industry should be open to re-litigation and to criminal prosecution as well.

Meanwhile I’m pursuing a couple of “think global, act local’ options here in Oregon that ought to get things moving a little pretty soon.

If you like what I’m trying to do here please hit that little donate button below and drop a thank you on me – I would appreciate knowing that you care about what I’m doing. Thanks.


by Leave a comment

“Anti-Tobacco” Movements Are Big Tobacco’s Useful Idiots

Here is a story is about an Australian oncologist who, dismayed at the damage that she saw “Tobacco” doing to her patients, was horrified to find out that her medical institution held “Tobacco” company stock as part of its investment portfolio.

Well, she set to work, she did, and although the gruff, cynical world of big money managers was skeptical at first, this plucky, photogenic Australian Oncologist has managed to create a very successful “Tobacco-free Portfolio” movement worldwide.

The article is chock full of feel-good quotes from financial wizards who were absolutely bowled over by the moral and ethical intensity of the Aussie doc’s arguments, and her ghastly photos of diseased lungs, and now they are 100% on board with her in shunning the “Tobacco” industry’s stocks in their portfolios.

The problem here is emblematic of the failure of anti-“tobacco” movements to even begin to identify who and what they need to be attacking. The core of the problem is that the industry has so completely propagandized people and institutions at all levels that most people actually believe that it is Tobacco killing all those people who die from smoking cigarettes.

While these movements and lawsuits and non-profit (sic) campaigns are all aimed at “Tobacco”, that plague-like carrier of the dreaded addictive nicotine toxin that destroys lives and stalks children, the industry slides right by because its products have almost nothing at all to do with Tobacco anymore. 100% of the attacks against the industry based on the assumption that its products are “Tobacco” are virtually meaningless and a complete waste of hope, energy, and money.

Almost all US cigarette brands are up to 100% recycled waste with nicotine added in precise dosages. Does anyone who reflects for even a few seconds believe that it would be possible to manufacture billions of cigarettes from natural plant material and be able to print the precise amount of tar and nicotine on every pack? The amount of nicotine varies so much from field to field, from plant to plant, and from leaf to leaf that even if they were using actual Tobacco leaf they couldn’t control the amount of “Nicotine & Tar” without doing some major processing.

The only way the industry can achieve uniformity is to produce a synthetic product, and in fact the industry does just that, by the millions of tons each year. The industry calls it “synthetic smoking materials” or, in a more colorful (and unconsciously accurate) industry term, “sheet tobacco”. That’s what it is – recycled waste processed into sheet of material that are then shaved, infused with precise amounts of hundreds of chemicals including nicotine, and then shaved into little curls and made into cigarettes. Anyone who knows the industry is laughing at the “Ammonia” lawsuit. Sure Ammonia is used in manufacturing “tobacco sheet” – huge amounts of it. But it isn’t “added” to the material, it’s used in a super-cooled process to puff it up after its been shaved into little curls so that it will look and smoke more like real leaf. The Ammonia is long-gone by the time those little ciggys are all packaged up and ready to be inhaled by some poor idiot who really is being deceived, manipulated, injured and murdered as a result of deliberate, profit-driven decisions of this industry.

If the 2016 US “Tobacco” industry were to be a startup industry with no history, and it came to even the highly-manipulated US regulators with the products it currently makes and proposed to make those products, they would not only be denied they would probably be arrested as terrorists.

But after many decades of very expensive and well-crafted propaganda, this industry now has even those who see it clearly as committing crimes against humanity led unknowingly to be aggrieved at “Tobacco” and to spend all their energy and resources attacking the “Tobacco industry”.

I’m afraid that for the most part anti-“Tobacco” people are useful idiots. They aren’t stupid, or foolish, or wrong in what they are trying to do. Bless them. However, they are being so effectively manipulated that they are the “Tobacco” industry’s most ardent defenders when it comes to anyone trying to point out the error of their “anti-Tobacco” ways.

In the 1980s I had written a four-part expose of the “Tobacco industry” at the request of a senior editor with the Nader organization, and just before that series was to begin publication, a senior member of Nader’s Board, a well-known “anti-Tobacco” physician, said (as my editor told me) that they had spent so many years convincing people that Tobacco was the worst possible thing for their health that they weren’t going to publish anything that might suggest that it might not be the Tobacco that’s the problem at all.

This industry is completely protected at the institutional/governmental level, and it seems that all of the “anti-Tobacco” movements in the world have also been effectively co-opted.

This industry has been earning more real wealth than any other tightly-held industry in the world for generations and that wealth has gone into ownership of hundreds of companies in every industry and every financial sector in the world. So as sincere and well-motivated as our Australian Oncologist is, I’m afraid that the hideous damage she sees in her “Tobacco” smoking patients has little or nothing to do with Tobacco, and the so-called “Tobacco” companies are fully divested out of range of any possible legal or regulatory action.

Many of those hundreds of companies owned by “Tobacco” money are consumer products, food, transportation, retail and leisure companies that advertise heavily in every medium. So any story about any strategy that had even a remote chance of actually harming the interests that profit directly or indirectly from the slaughter would not make it into any medium that relies on advertising. Stories that are really dangerous to the “tobacco” industry somehow don’t make it through the media screening process. And there’s not a whiff of “tobacco” anywhere in the room where the decision is made to kill the story at the editorial level – they’ve simply heard from a few of their best retailer and consumer products advertisers. I have personally seen this happen.

So you can be that the “Tobacco industry” isn’t worried about the “Tobacco-free Portfolio” movement one bit.

Divesting “Tobacco” company stock as a means to rein in their murderous behavior is worse than ineffective – it makes people feel that they are actually accomplishing something. No portfolio manager could divest of every stock and bond connected to every company owned by “Tobacco” money – there wouldn’t be many stocks or bonds left to own.

But you can’t even scratch the “Tobacco” industry by selling off its stocks. However, the industry still puts on a good show for the quixotic victors whenever someone like our plucky Aussie Oncologist does appear.

It fights and fights and then gives up and wails and gnashes its teeth – just like it did with the “big” Tobacco Liability settlements a few years ago. “Oh stop, stop. Here, take a few billion dollars. You’ve got us. We give up. We’ll do better from now on.”

We’ve all heard it and seen it and while a lot of us know it’s just an act very few of us can see what a truly well-crafted act it is. This act cost hundreds of millions, probably billions of dollars and decades to craft to perfection. The industry has been hiring the best behavior modification scientists in the world for decades, along with thousands of other scientists in many other disciplines, either directly or through hidden sponsorship with “research grants”. The industry almost has a 100% effective mindset in place at all levels of society, and keeping people fixated on “Tobacco” and “Nicotine” is at the core of the strategy.

However, if you have read this far you are one of the people that the “Tobacco” industry really, really hopes will just shrug your shoulders and walk away. Oh well, it’s all true but what can be done about it?

I do have a small suggestion. A class action lawsuit that actually identifies a class of cigarette smokers that consists of people who have been damaged by this industry in specific ways by cigarette products based on a specific, broad and deep knowledge ON THE PART OF THE ATTORNEYS of how the industry operates, would succeed quite nicely and not just in a monetary awards for the plaintiffs. Such a lawsuit could actually lead to meaningful change, if not from the existing “Tobacco” industry then from an alternative heirloom, truly natural Tobacco movement on the local level, perhaps right alongside legalized Cannabis. I don’t believe this kind of legal action has ever been tried, but would love to hear from anyone who knows of such a case.

This industry’s vulnerability is that it is so wealthy, powerful, diversified and protected that it has come to rely completely on its ability to keep on fooling all the people all the time. This industry believes that it controls all of the rules of the game that it has us all playing. And Rule #1 is that we all agree that Tobacco and Nicotine are the problems. So, all together now …..

This industry is pure psychosis in institutional form.